Furthermore, our results showed that the IL-32 sera levels significantly correlated with the sPAP evaluated with echocardiography, which is a non-invasive and feasible assessment of suspected PAH according to current guidelines [14, 52]. The gene discussed is IL32; the disease is pulmonary arterial hypertension.